CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,330 shares at $0.81 ($2,711)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change
- 4 Derivatives Options or other derivatives
Page 26 of 46 · 907 filings